Indication
Ulcerative proctitis
Ulcerative proctitis is a localized phenotypic subtype of ulcerative colitis, a chronic inflammatory bowel disease affecting the lower gastrointestinal tract. Read more about Ulcerative proctitis
32 drugs 24 manufacturers
Drugs that treat it
Common Ulcerative proctitis therapies.
MESALAMINE (mesalamine with cleansing wipes)
MESALAMINE
MESALAMINE
MESALAMINE (mesalamine with cleansing wipes)
MESALAMINE (mesalamine with cleansing wipes)
MESALAMINE (mesalamine with cleansing wipes)
MESALAMINE (mesalamine with cleansing wipes)
CANASA (mesalamine)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonUlcerative proctitis is a localized phenotypic subtype of ulcerative colitis, a chronic inflammatory bowel disease affecting the lower gastrointestinal tract.
The condition is confined strictly to the rectal mucosa, originating at the dentate line and extending proximally without exceeding approximately fifteen centimeters from the anal verge.
Pathophysiologically driven by immune-mediated epithelial barrier dysfunction and mucosal inflammation, it is characterized endoscopically by confluent mucosal erythema, friability, and ulceration.
Clinically, affected patients most commonly present with recurrent hematochezia, fecal urgency, tenesmus, and the passage of rectal mucus, while systemic manifestations remain infrequent.
- medlineplus.gov
Ulcerative proctitis is a localized phenotypic subtype of ulcerative colitis, a chronic inflammatory bowel disease affecting the lower gastrointestinal tract
- nih.gov
Ulcerative proctitis is a localized phenotypic subtype of ulcerative colitis, a chronic inflammatory bowel disease affecting the lower gastrointestinal tract
- nih.gov
The condition is confined strictly to the rectal mucosa, originating at the dentate line and extending proximally without exceeding approximately fifteen centimeters from the anal verge
- nih.gov
The condition is confined strictly to the rectal mucosa, originating at the dentate line and extending proximally without exceeding approximately fifteen centimeters from the anal verge Pathophysiologically driven by immune-mediated epithelial barrier dysfunction and mucosal inflammation, it is characterized endoscopically by confluent mucosal erythema, friability, and ulceration Clinically, affected patients most commonly present with recurrent hematochezia, fecal urgency, tenesmus, and the pas...
- amegroups.org
Pathophysiologically driven by immune-mediated epithelial barrier dysfunction and mucosal inflammation, it is characterized endoscopically by confluent mucosal erythema, friability, and ulceration
- nih.gov
Clinically, affected patients most commonly present with recurrent hematochezia, fecal urgency, tenesmus, and the passage of rectal mucus, while systemic manifestations remain infrequent
Personalize your experience
Follow Ulcerative proctitis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.